| Molecular Biology of Prostate Cancer Y Chen, CL Sawyer DeVita, Hellman, and Rosenberg's cancer: principles & practice of oncology 2, 2008 | 6665* | 2008 |
| Integrative clinical genomics of advanced prostate cancer D Robinson, EM Van Allen, YM Wu, N Schultz, RJ Lonigro, JM Mosquera, ... Cell 161 (5), 1215-1228, 2015 | 3629 | 2015 |
| Development of a second-generation antiandrogen for treatment of advanced prostate cancer C Tran, S Ouk, NJ Clegg, Y Chen, PA Watson, V Arora, J Wongvipat, ... Science 324 (5928), 787-790, 2009 | 2655 | 2009 |
| The molecular taxonomy of primary prostate cancer A Abeshouse, J Ahn, R Akbani, A Ally, S Amin, CD Andry, M Annala, ... Cell 163 (4), 1011-1025, 2015 | 2589 | 2015 |
| Organoid cultures derived from patients with advanced prostate cancer D Gao, I Vela, A Sboner, PJ Iaquinta, WR Karthaus, A Gopalan, ... Cell 159 (1), 176-187, 2014 | 1455 | 2014 |
| Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway VS Viswanathan, MJ Ryan, HD Dhruv, S Gill, OM Eichhoff, ... Nature 547 (7664), 453-457, 2017 | 1366 | 2017 |
| Reciprocal feedback regulation of PI3K and androgen receptor signaling in PTEN-deficient prostate cancer BS Carver, C Chapinski, J Wongvipat, H Hieronymus, Y Chen, ... Cancer cell 19 (5), 575-586, 2011 | 1305 | 2011 |
| ARN-509: a novel antiandrogen for prostate cancer treatment NJ Clegg, J Wongvipat, JD Joseph, C Tran, S Ouk, A Dilhas, Y Chen, ... Cancer research 72 (6), 1494-1503, 2012 | 763 | 2012 |
| Identification of multipotent luminal progenitor cells in human prostate organoid cultures WR Karthaus, PJ Iaquinta, J Drost, A Gracanin, R Van Boxtel, J Wongvipat, ... Cell 159 (1), 163-175, 2014 | 712 | 2014 |
| Organoid culture systems for prostate epithelial and cancer tissue J Drost, WR Karthaus, D Gao, E Driehuis, CL Sawyers, Y Chen, H Clevers Nature protocols 11 (2), 347-358, 2016 | 570 | 2016 |
| PRC2 is recurrently inactivated through EED or SUZ12 loss in malignant peripheral nerve sheath tumors W Lee, S Teckie, T Wiesner, L Ran, CN Prieto Granada, M Lin, S Zhu, ... Nature genetics 46 (11), 1227-1232, 2014 | 531 | 2014 |
| Androgen receptor signaling regulates DNA repair in prostate cancers WR Polkinghorn, JS Parker, MX Lee, EM Kass, DE Spratt, PJ Iaquinta, ... Cancer discovery 3 (11), 1245-1253, 2013 | 525 | 2013 |
| Targeting the androgen receptor pathway in prostate cancer YU Chen, CL Sawyers, HI Scher Current opinion in pharmacology 8 (4), 440-448, 2008 | 507 | 2008 |
| N-Myc induces an EZH2-mediated transcriptional program driving neuroendocrine prostate cancer E Dardenne, H Beltran, M Benelli, K Gayvert, A Berger, L Puca, J Cyrta, ... Cancer cell 30 (4), 563-577, 2016 | 503 | 2016 |
| Overcoming mutation-based resistance to antiandrogens with rational drug design MD Balbas, MJ Evans, DJ Hosfield, J Wongvipat, VK Arora, PA Watson, ... elife 2, e00499, 2013 | 448 | 2013 |
| Anti-androgens and androgen-depleting therapies in prostate cancer: new agents for an established target Y Chen, NJ Clegg, HI Scher The lancet oncology 10 (10), 981-991, 2009 | 435 | 2009 |
| Defective acidification in human breast tumor cells and implications for chemotherapy N Altan, Y Chen, M Schindler, SM Simon The Journal of experimental medicine 187 (10), 1583-1598, 1998 | 362 | 1998 |
| ETV1 is a lineage survival factor that cooperates with KIT in gastrointestinal stromal tumours P Chi, Y Chen, L Zhang, X Guo, J Wongvipat, T Shamu, JA Fletcher, ... Nature 467 (7317), 849-853, 2010 | 339 | 2010 |
| ETS factors reprogram the androgen receptor cistrome and prime prostate tumorigenesis in response to PTEN loss Y Chen, P Chi, S Rockowitz, PJ Iaquinta, T Shamu, S Shukla, D Gao, ... Nature medicine 19 (8), 1023-1029, 2013 | 317 | 2013 |
| Recurrent activating mutations of G-protein-coupled receptor CYSLTR2 in uveal melanoma AR Moore, E Ceraudo, JJ Sher, Y Guan, AN Shoushtari, MT Chang, ... Nature genetics 48 (6), 675-680, 2016 | 302 | 2016 |
Charles SawyersMemorial Sloan Kettering Cancer CenterVerified email at mskcc.org
